← All trials
NCT04942002
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 15, 2021
- Primary completion
- Jun 15, 2023
- Completion date
- Sep 15, 2023
- First posted
- Jun 28, 2021
- Last posted
- Jun 28, 2021
- Enrollment
- 50
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Asociación para Evitar la Ceguera en MéxicoLead sponsor
- Asociación para Evitar la Ceguera en MéxicoStudy director
- Asociación para Evitar la Ceguera en MéxicoOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.